Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Library

CorMedix

CorMedix Inc.: A US-based biopharmaceutical firm specializing in cardiac, renal, and inflammatory disease treatments.

Berkeley Heights, NJ, US🇺🇸

Founded

Loading

CorMedix Website, Blog & Press Pages - aVenture

CorMedix - Library

cormedix.comCrawled Oct 15, 2026

Topics

Publication type

Search the library

Content origin

Row density

Careers & Hiring

3 pages

bg-careers/careers/bg-careers
Bsanner Careers/careers/bsanner-careers
Careers/careers

Team

3 pages

Management/company/management-team
Khoso Baluch was appointed Chief Executive Officer in October 2016 and has led sales teams in the U.S. and internationally. Products launched include Cialis, Byetta, insulin devices, Cimzia, Vimpat, and Neupro.
Verwaltungsrat/company/board-of-directors
Cora M. Tellez joined CorMedix’s Board of Directors in April 2014 and was elected chairwoman that month. She is president and CEO of Sterling HSA, which she founded in 2004, and has 25 years of experience in healthcare financing and delivery.
Wissenschaftliche Berater/company/wissenschaftliche-berater
The page lists Professor Dr. med. Christoph Wanner, Professor Dr. med. Markus Ketteler, and Professor Dr. med. Markus Hollenbeck with their medical titles and institutional affiliations.

About

1 page

Company/company
Cormedix Europe GmbH is a wholly owned subsidiary of CorMedix Inc., a pharmaceutical company focused on taurolidine technology. Its first commercial product, Neutrolin, is a non-antibiotic antimicrobial solution with CE marking in Europe.

Contact

1 page

Contact Us/contact-us

Homepage

1 page

Homepage/

Privacy

1 page

Privacy/privacy
The page outlines CorMedix’s privacy statement for its website and says it provides visitors with information about what personal information is collected and how.